Pharmacy World and Science

, Volume 21, Issue 6, pp 266–269 | Cite as

The use of eardrops in an ENT department

  • S. Natsch
  • E.A.M. Mylanus
  • J.J.S. Mulder
  • Y.A. Hekster


A survey of the pattern of usage of ototopical preparations in out‐patients of the ENT department of a Dutch University Hospital has been performed. Data on clinical presentation and previous treatment of the patient, otoscopic results, prescribed current treatment and, if available, results of microbiological examination were collected. One‐hundred and twenty‐one evaluable patients were prospectively included. For 20% of the patients it concerned a first manifestation of the symptoms, 35% had a recurrence after a period free of symptoms and in 37% it concerned patients with persisting symptoms despite treatment. Forty‐five percent of the patients' ears concerned had an intact tympanic membrane, in 25% a perforation was present and in 12% middle ear ventilation tubes were in situ. Thirty‐five percent had already received previous treatment with ear drops. The species most often isolated was Staphylococcus aureus, followed by Pseudomonas aeruginosa. A wide range of products were prescribed. While previous treatment occurred with combination preparations, for current prescriptions, ofloxacin was most often used. Most patients received 2 to 3 drops 3 times a day for 7 to 10 days, which is in accordance with recommendations in the literature. Potentially ototoxic substances are regularly used in daily practice. Ofloxacin is widely used even though it is not registered for this indication in the Netherlands and the development of resistance has to be taken into account. A new policy based on this survey is proposed, which will reduce the number of different preparations used and will eliminate ofloxacin from first line treatment.

Drug utilisation review Ear diseases Ear drops Otitis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Roland PS. Clinical ototoxicity of topical antibiotic drops. Otolaryngol Head Neck Surg 1994;110(6):598-602.Google Scholar
  2. 2.
    Hui Y, Park A, Crysdale WS, Forte V. Ototoxicity from ototopical aminoglycosides. J Otolaryngol 1997;26(1):53-6.Google Scholar
  3. 3.
    Wong DLH, Rutka JA. Do aminoglycoside otic preparations cause ototoxicity in the presence of tympanic membrane perforations? Otolaryngol Head Neck Surg 1997;116(3):404-10.Google Scholar
  4. 4.
    Linder TE, Zwicky S, Braendle P. Ototoxicity of ear drops: a clinical perspective. Am J Otol 1995;16(5):653-7.Google Scholar
  5. 5.
    Marais J, Rutka JA. Ototoxicity and topical eardrops. Clin Otolaryngol 1998;23:360-7.Google Scholar
  6. 6.
    Lundy LB, Graham MD. Ototoxicity and ototopical medications: a survey of otolaryngologists. Am J Otol 1993;14(2):141-6.Google Scholar
  7. 7.
    Kuhweide R. Experimental evidence of ototoxicity of ear drops; a review of the literature. Acta Otorhinolaryngol Belg 1995;49:293-8.Google Scholar
  8. 8.
    Rakover Y, Keywan K, Rosen G. Safety of topical ear drops containing ototoxic antibiotics. J Otolaryngol 1997;26(3):194-6.Google Scholar
  9. 9.
    Merifield DO, Parker NJ, Nicholson NC. Therapeutic management of chronic suppurative otitis media with otic drops. Otolaryngol Head Neck Surg 1993;109(1):77-82.Google Scholar
  10. 10.
    Welling DB, Forrest LA, Goll III F. Safety of ototopical antibiotics. Laryngoscope 1995;105:472-4.Google Scholar
  11. 11.
    Podoshin L, Fradis M, Ben David J. Ototoxicity of ear drops in patients suffering from chronic otitis media. J Laryngol Otol 1989;103(1):46-50.Google Scholar
  12. 12.
    Goycoolea MV, Lundman L. Round window membrane. Structure function and permeability: a review. Microsc Res Tech 1997;36:201-11.Google Scholar
  13. 13.
    Pigatto PD, Bigardi A, Legori A, Altomare G, Troiano L. Allergic contact dermatitis prevalence in patients with otitis externa. Acta Derm Venereol 1991;71(2):162-5.Google Scholar
  14. 14.
    Van Ginkel CJ, Bruintjes TD, Huizing EH. Allergy due to topical medications in chronic otitis externa and chronic otitis media. Clin Otolaryngol 1995;20(4):326-8.Google Scholar
  15. 15.
    Tange RA, Boumans LJJM, Hulst RJAM van der. Oordruppels en ototoxiciteit. Ned Tijdschr KNO heelkunde 1995;1:46-49.Google Scholar
  16. 16.
    Nederlandse Vereniging voor Keel-, Neus-, Oor-heelkunde en Heelkunde van het Hoofd-Halsgebied. Standpuntnota nr. 2: Gebruik van oordruppels met (aminoglycoside-)antibiotica en corticosteroiden bij otitis media met trommelvliesperforatie en in operatieholtes. Ned Tijdschr KNO heelkunde 1995;1:51.Google Scholar
  17. 17.
    Bluestone CD, Klein JO. Otitis media with effusion, atelectasis and eustachian tube dysfunction. In Bluestone CD, Stool SE, eds: Pediatric otolaryngology, vol.1, Philadelphia: W.B. Saunders Co. 1983.Google Scholar
  18. 18.
    Harker LA, Koontz FP. The bacteriology of cholesteatoma. In McCabe BF, Sade J, Abramson M, eds: Cholesteatoma first international conference, Birmingham, Ala: Aesculapius Publishing Co. 1977.Google Scholar
  19. 19.
    Senturia BH, Marcus MD, Lucente FE. Diseases of the external ear: an otologic-dermatologic manual. 2nd ed. New York: Grune & Stratton, 1980.Google Scholar
  20. 20.
    Morizono T, Paparella MM, Juhn SK. Ototoxicity of propylene glycol in experimental animals. Am J Otolaryngol 1980;1(5):393-9.Google Scholar
  21. 21.
    Ikeda K, Morizono T. The preparation of acetic acid for use in otic drops and its effect on endocochlear potential and pH in inner ear fluid. Am J Otolaryngol 1989;10(6):382-5.Google Scholar
  22. 22.
    Rohn GN, Meyerhoff WL, Wright CG. Ototoxicity of topical agents. Otolaryngol Clin North Am 1993;26(5):747-58.Google Scholar
  23. 23.
    Knauf HP, Silvany R, Southern PM, Risser RC, Wilson SE. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea 1996;15(1):66-71.Google Scholar
  24. 24.
    Hunter LL, Margolis RH, Rykken JR, Le CT, Daly KA, Giebink CS. High frequency hearing loss associated with otitis media. Ear Hear 1996;17:1-11.Google Scholar
  25. 25.
    Morizono T, Tono T. Middle ear inflammatory mediators and cochlear function. Otolaryngol Clin North Am 1991;24(4):835-43.Google Scholar
  26. 26.
    Morizono T. Toxicity of ototopical drugs: animal modeling. Ann Otol Rhinol Laryngol 1990;99:42-5.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • S. Natsch
  • E.A.M. Mylanus
  • J.J.S. Mulder
  • Y.A. Hekster

There are no affiliations available

Personalised recommendations